Stockscreener 앱 받기
53.07
0.70%
0.37
시간 외 거래:
53.50
0.43
+0.81%
Exact Sciences Corp 주식(EXAS)의 최신 뉴스
Cathie Wood's ARK buys Tempus AI stock, sells Exact Sciences - Investing.com
Swiss National Bank Increases Holdings in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
Madison-based Exact Sciences reports Q3 results short of analysts’ expectations - Chippewa Herald
EULAV Asset Management Has $20.78 Million Position in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
Exact Sciences Corporation (EXAS): Among the Best Genomics Stocks to Buy Right Now - Insider Monkey
Exact Sciences Co. (NASDAQ:EXAS) Sees Large Drop in Short Interest - MarketBeat
Exact Sciences Co. (NASDAQ:EXAS) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Exact Sciences Partners with Actor and TV Personality Carlos Ponce to Increase Awareness of Colon Cancer Screening Among Hispanic Community - Business Wire
EXAS Stock Set to Benefit From Favorable Study Data Backing MCED Test - Yahoo Finance
Chairman of The Board & CEO of Exact Sciences Picks Up 2.7% More Stock - Yahoo Finance
Exact Sciences Co. (NASDAQ:EXAS) Shares Acquired by Simplify Asset Management Inc. - MarketBeat
Exact Sciences showcases early cancer detection test data at AACR meeting - Clinical Trials Arena
Exact Sciences Co. (NASDAQ:EXAS) Shares Sold by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Exact Sciences Unveils Data Showing Promise of Multi-Cancer Early Detection at AACR Special Conference on Liquid Biopsy - BioSpace
Capital World Investors Reduces Stake in Exact Sciences Corp - GuruFocus.com
Exact Sciences CEO Kevin Conroy buys $1 million in stock By Investing.com - Investing.com Nigeria
Exact Sciences reports progress in early cancer detection - Investing.com
Exact Sciences reports progress in early cancer detection By Investing.com - Investing.com UK
Exact Sciences CEO Kevin Conroy buys $1 million in stock - Investing.com India
Exact Sciences' Cancer Test Shows 28% Better Early Detection, Could Cut Deaths by 17% | EXAS Stock News - StockTitan
Los Angeles Capital Management LLC Takes Position in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
Exact Sciences Corp (EXAS) Stock Price Down 6.11% on Nov 12 - GuruFocus.com
Exact Sciences Co. (NASDAQ:EXAS) Shares Purchased by WCM Investment Management LLC - MarketBeat
Exact Sciences Corporation (EXAS) Rebounded from the Previous Quarter - Yahoo Finance
15,260 Shares in Exact Sciences Co. (NASDAQ:EXAS) Acquired by Lisanti Capital Growth LLC - MarketBeat
Exact Sciences: Cancer Detection Stalwart's Bad Quarter Resets Its Overgrown Market Cap. - Seeking Alpha
Exact Sciences Co. (NASDAQ:EXAS) Shares Sold by Principal Financial Group Inc. - MarketBeat
Wellington Management Group LLP Reduces Stake in Exact Sciences Corp - GuruFocus.com
ARK Investment Management LLC Sells 117,043 Shares of Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
Analysts Set Expectations for Exact Sciences Q4 Earnings - MarketBeat
Exact Sciences’ forecast cut shocks analysts - Yahoo Finance
Exact Sciences Corporation (NASDAQ:EXAS) Q3 2024 Earnings Call Transcript - Insider Monkey
Van ECK Associates Corp Sells 17,484 Shares of Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
Exact Sciences Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
Exact Sciences: Q3 Sell-Off May Be Unjustified But Long-Term Outlook A Concern (EXAS) - Seeking Alpha
Cologuard Maker Exact Sciences Slashes Outlook as Losses Mount - Yahoo Finance
Piper Sandler maintains Overweight rating on Exact Sciences shares - Investing.com
Exact Sciences stock target cut by Benchmark, retains Buy rating - Investing.com
Exact Sciences (NASDAQ:EXAS) Shares Gap Down on Disappointing Earnings - MarketBeat
Colorectal Cancer Diagnostic Focused Exact Sciences Stock Plunges On Weak Annual Guidance, Analyst Sees Compelling Long-Term Entry Point - Yahoo Finance
Exact Sciences (NASDAQ:EXAS) Given New $65.00 Price Target at Benchmark - MarketBeat
Craig Hallum Issues Pessimistic Forecast for Exact Sciences (NASDAQ:EXAS) Stock Price - MarketBeat
Exact Sciences Stock Down On Q3 Earnings & Revenue Miss, '24 View Cut - Barchart
Exact Sciences (NASDAQ:EXAS) Price Target Lowered to $67.00 at Robert W. Baird - MarketBeat
Exact Sciences stock target cut, outperform rating on revenue outlook - Investing.com
Exact Sciences Stock Down on Q3 Earnings & Revenue Miss, '24 View Cut - Yahoo Finance
Exact Sciences Collapses On 'Alarming' Guidance Cut. Is The Growth Story Broken? - Yahoo! Voices
Exact Sciences Corp (EXAS) Q3 2024 Earnings Call Highlights: Str - GuruFocus.com
Exact Sciences Corp (EXAS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ... - Yahoo Finance
Decoding Exact Sciences Corp (EXAS): A Strategic SWOT Insight - GuruFocus.com
Exact Sciences Reports Strong Q3 Performance and Pipeline Advances - TipRanks
Exact Sciences Announces Third-Quarter 2024 Results - BioSpace
Exact Sciences (EXAS) Q3 2024 Earnings Call Transcript - Yahoo Finance
Exact Sciences (EXAS) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance
Exact Sciences: Q3 Earnings Snapshot - San Antonio Express-News
EXACT Sciences earnings missed, revenue fell short of estimates - Investing.com
Exact Sciences Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
After-hours movers: Super Micro Computer, Exact Sciences, Trump Media & Technology - Investing.com
Exact Sciences Stock Plummets After Worse-Than-Expected Q3 Results, FY24 Guidance Below Estimates - Benzinga
Exact Sciences Corp Q3 2024 Earnings: Revenue at $709M, EPS at -$0.21, Misses Estimates - GuruFocus.com
0.98%
0.01%
자본화:
|
볼륨(24시간):